Free Trial
NASDAQ:ESTA

Establishment Labs (ESTA) Stock Price, News & Analysis

$40.69
-0.30 (-0.73%)
(As of 11:50 AM ET)
Today's Range
$40.06
$41.12
50-Day Range
$34.40
$48.99
52-Week Range
$16.96
$60.12
Volume
28,213 shs
Average Volume
353,067 shs
Market Capitalization
$1.12 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$56.60

Establishment Labs MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.80 Rating Score
Upside/​Downside
39.1% Upside
$56.60 Price Target
Short Interest
Bearish
20.18% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.46mentions of Establishment Labs in the last 14 days
Based on 4 Articles This Week
Insider Trading
Selling Shares
$647,806 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($2.12) to ($1.08) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.29 out of 5 stars

Medical Sector

589th out of 911 stocks

Surgical Appliances & Supplies Industry

14th out of 17 stocks

ESTA stock logo

About Establishment Labs Stock (NASDAQ:ESTA)

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

ESTA Stock Price History

ESTA Stock News Headlines

Trillion Dollar Blockchain Shift Could Trigger THIS Coin
It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…
Trillion Dollar Blockchain Shift Could Trigger THIS Coin
It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…
Establishment Labs earnings preview: what Wall Street is expecting
See More Headlines
Receive ESTA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Establishment Labs and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/06/2024
Today
9/12/2024
Next Earnings (Estimated)
11/05/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical appliances & supplies
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:ESTA
Fax
N/A
Employees
960
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$56.60
High Stock Price Target
$70.00
Low Stock Price Target
$45.00
Potential Upside/Downside
+39.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
5 Analysts

Profitability

Net Income
$-78,500,000.00
Pretax Margin
-55.61%

Debt

Sales & Book Value

Annual Sales
$151.35 million
Book Value
$0.71 per share

Miscellaneous

Free Float
24,367,000
Market Cap
$1.12 billion
Optionable
Optionable
Beta
1.20
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Mr. Juan Jose Chacon QuirosMr. Juan Jose Chacon Quiros (Age 52)
    Founder, CEO & Executive Director
    Comp: $913.37k
  • Mr. Rajbir Singh Denhoy (Age 54)
    Chief Financial Officer
    Comp: $570.29k
  • Mr. S. Ross Mansbach (Age 57)
    General Counsel & Chief Compliance Officer
    Comp: $379.53k
  • Mr. Roberto de Mezerville (Age 43)
    Chief Technology Officer
  • Mr. Salvador Santos Dada (Age 42)
    Head of Special Projects
    Comp: $468.62k
  • Ms. Rosalyn Cole d'Incelli
    SVP of Global Clinical, Medical & US Regulatory Affairs
  • Ms. Elizabeth Panzica Newman
    VP & Head of U.S Business Unit
  • Mr. Ivan Bilic
    Senior Vice President of Commercial Operations - OUS
  • Ms. Neeta Toprani
    Corporate Secretary

ESTA Stock Analysis - Frequently Asked Questions

How have ESTA shares performed this year?

Establishment Labs' stock was trading at $25.89 on January 1st, 2024. Since then, ESTA shares have increased by 57.2% and is now trading at $40.69.
View the best growth stocks for 2024 here
.

How were Establishment Labs' earnings last quarter?

Establishment Labs Holdings Inc. (NASDAQ:ESTA) announced its quarterly earnings data on Tuesday, August, 6th. The company reported ($0.62) earnings per share for the quarter, missing the consensus estimate of ($0.51) by $0.11. Establishment Labs's revenue was down 9.2% compared to the same quarter last year.

When did Establishment Labs IPO?

Establishment Labs (ESTA) raised $50 million in an initial public offering on Thursday, July 19th 2018. The company issued 3,100,000 shares at a price of $15.00-$17.00 per share. Jefferies and Cowen acted as the underwriters for the IPO and BTIG was co-manager.

Who are Establishment Labs' major shareholders?

Establishment Labs' top institutional investors include Nantahala Capital Management LLC (9.13%), Rice Hall James & Associates LLC (2.60%), William Blair Investment Management LLC (1.75%) and Sofinnova Investments Inc. (1.56%). Insiders that own company stock include Jw Asset Management, Llc, Nicholas Sheridan Lewin, Quiros Juan Jose Chacon, Raj Denhoy, Leslie Gillin and Edward J Schutter.
View institutional ownership trends
.

How do I buy shares of Establishment Labs?

Shares of ESTA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Establishment Labs own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Establishment Labs investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Sientra (SIEN), Allergan (AGN), BCE (BCE), Canadian Imperial Bank of Commerce (CM) and

This page (NASDAQ:ESTA) was last updated on 9/12/2024 by MarketBeat.com Staff

From Our Partners